Shotgun Metaproteomics of the Human Distal Gut Microbiota

Total Page:16

File Type:pdf, Size:1020Kb

Shotgun Metaproteomics of the Human Distal Gut Microbiota The ISME Journal (2009) 3, 179–189 & 2009 International Society for Microbial Ecology All rights reserved 1751-7362/09 $32.00 www.nature.com/ismej ORIGINAL ARTICLE Shotgun metaproteomics of the human distal gut microbiota Nathan C Verberkmoes1,7, Alison L Russell1,7, Manesh Shah1, Adam Godzik2, Magnus Rosenquist3,8, Jonas Halfvarson4, Mark G Lefsrud1,9, Juha Apajalahti5, Curt Tysk4, Robert L Hettich1 and Janet K Jansson3,6 1Oak Ridge National Laboratory, Chemical and Life Sciences Divisions, Oak Ridge, TN, USA; 2Department of Bioinformatics and Systems Biology, Burnham Institute for Medical Research, La Jolla, CA, USA; 3Department of Microbiology, Swedish University of Agricultural Sciences, Uppsala, Sweden; 4Department of Internal Medicine, Division of Gastroenterology, O¨rebro University Hospital, O¨rebro, Sweden; 5Alimetrics Ltd, Helsinki, Finland and 6Department of Ecology, Earth Science Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA The human gut contains a dense, complex and diverse microbial community, comprising the gut microbiome. Metagenomics has recently revealed the composition of genes in the gut microbiome, but provides no direct information about which genes are expressed or functioning. Therefore, our goal was to develop a novel approach to directly identify microbial proteins in fecal samples to gain information about the genes expressed and about key microbial functions in the human gut. We used a non-targeted, shotgun mass spectrometry-based whole community proteomics, or metaproteomics, approach for the first deep proteome measurements of thousands of proteins in human fecal samples, thus demonstrating this approach on the most complex sample type to date. The resulting metaproteomes had a skewed distribution relative to the metagenome, with more proteins for translation, energy production and carbohydrate metabolism when compared to what was earlier predicted from metagenomics. Human proteins, including antimicrobial peptides, were also identified, providing a non-targeted glimpse of the host response to the microbiota. Several unknown proteins represented previously undescribed microbial pathways or host immune responses, revealing a novel complex interplay between the human host and its associated microbes. The ISME Journal (2009) 3, 179–189; doi:10.1038/ismej.2008.108; published online 30 October 2008 Subject Category: microbe–microbe and microbe–host interactions Keywords: microbiome; human gut; metaproteome; shotgun proteomics; metagenomics; antimicrobial peptide Introduction has a unique and relatively stable gut microbiota, unless disrupted by external factors such as anti- The human gastrointestinal (GI) tract is host for 11 biotic treatment (Jernberg et al., 2007). Increasing myriads of microorganisms (approximately 10 evidence suggests that the composition of the GI per g feces) that carry out vital processes for normal microbiota is linked to inflammatory bowel diseases digestive functions of the host and play an impor- (Peterson et al., 2008), such as Crohn’s disease tant, although not yet not fully understood, role in (Dicksved et al., 2008), and can even influence the maturation of human immunity and defense against propensity for obesity (Ley et al., 2006). Current pathogens. Recent findings suggest that each human estimates, based on sequencing of 16S rRNA genes in DNA extracted from feces, are that 800–1000 different Correspondence: JK Jansson, Earth Science Division, Lawrence microbial species and 47000 different strains inhabit Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, the GI tract (Ba¨ckhead et al., 2005) and that the CA 94720, USA. majority of these (480%) have not yet been isolated E-mail: [email protected] 7These authors contributed equally to this work. or characterized (Eckburg et al., 2005). Therefore, 8Current address: Department of Oncology, Radiology and there is a vast microbial diversity with largely Clinical Immunology, Uppsala University Hospital, Uppsala, unknown function that is waiting to be explored. Sweden. Recently, metagenomic sequencing has revealed 9 Current address: Bioresource Engineering, McGill University, information about the complement of genes in the Ste-Anne-de-Bellevue, Quebec, Canada. Received 2 September 2008; revised 7 October 2008; accepted 8 gut microbiota of two healthy individuals (Gill et al., October 2008; published online 30 October 2008 2006). Although this dataset did not represent the Human gut metaproteome NC Verberkmoes et al 180 entire GI microbiota, analysis of identified genes can be confidently and reproducibly measured (that revealed that the GI microbiome has significantly is, with high specificity and low false-positive rates; enriched capacities for glycan, amino-acid and 1–5% maximum) from gut microorganisms by xenobiotic metabolism, methanogenesis, and synth- comparing with available metagenome databases esis of vitamins and isoprenoids. This indirect (Gill et al., 2006) and available gut isolate genomes evidence suggested that there are unique microbial and to determine whether unmatched datasets functions carried out in the gut environment. could suffice for accurate protein identifications. A major limitation of DNA-based approaches is An additional goal was to apply a novel bioinfor- that they predict potential functions, but it is not matics approach to assign putative functions to known whether the predicted genes are expressed at unknown proteins not covered by standard analysis all or if so, under what conditions and to what of clusters of orthologous groups (COGs). Ultimately, extent. In addition, it is not possible to determine our aim was to use the protein data to provide direct whether the DNA is from cells that are active and evidence of dominant and key microbial functions in viable, dormant or even dead. These limitations can the human gut for the first time, some of which could be overcome by directly assessing proteins, because serve as indicators of a healthy or diseased state. In the genes must have been transcribed and translated addition, this non-targeted approach enables identi- to produce a protein product. However, to date only fication of human proteins associated with the gut a couple of microbial proteins have been identified microbiota, thus illustrating potential interactions from the human gut and these were obtained by two- between the human microbiome and host. dimensional (2D) PAGE (Klaassens et al., 2007), followed by excision and de novo sequencing of targeted spots on the gel. Materials and methods Here, our aim was to develop a novel high- Fecal sample collection throughput, non-targeted mass spectrometry (MS) A female healthy monozygotic twin pair born in 1951 approach to determine the identities of thousands of was invited to take part in a larger double-blinded microbial proteins in the most complex sample type study, and details of these individuals with respect to to date (that is, feces) and to test the feasibility of diet, antibiotic usage, and so on are described earlier: using a non-matched metagenome dataset for individuals numbered 6a and 6b (Dicksved et al., protein identification. This MS-based shotgun 2008), who provided samples 7 and 8, respectively, proteomics approach relies on detection and identi- were the focus of this study. The only differences fication of all proteins in a lysed cell mixture between the individuals according to the submitted without the need for gel-based separation or de questionnaire data were that individual 6a had novo sequencing. Instead, the resulting peptides gastroenteritis and individual 6b had taken non- from an enzymatic digest of the entire proteome are steroidal anti-inflammatory drugs during the past 12 separated by liquid chromatography and infused months. Fecal samples were collected in 20 ml directly into rapidly scanning tandem mass spectro- colonic tubes by the twins and immediately sent to meters (2D-LC-MS/MS) through electrospray ioniza- O¨ rebro University Hospital on the day of collection, tion. The resulting peptide mass information and where they were placed at À70 1C and stored. The tandem mass spectra are used to search against Uppsala County Ethics Committee and the Oak Ridge protein databases generated from genome se- National Laboratory (ORNL) human study review quences. To date, the shotgun metaproteomics panel approved the study. approach has only been demonstrated in a limited number of studies and only for microbial commu- nities with low diversity, such as acid mine drainage Microbial cell extraction from fecal samples systems (Ram et al., 2005; Lo et al., 2007), Fecal samples were thawed at þ 4 1C and microbial endosymbionts (Markert et al., 2007) and sewage cells were extracted from the bulk fecal material by sludge water (Wilmes et al., 2008). It remains a differential centrifugation, as described earlier technical challenge to apply this shotgun approach (Apajalahti et al., 1998). This cell extraction method to more complex microbial communities, such as has previously been found to result in a highly those inhabiting the human gut. enriched bacterial fraction from complex samples, For this study, it was first necessary to develop the such as soil and chicken feces, with negligible shotgun proteomics approach to work with fecal bacterial cell loss and a good representation of fecal samples containing large amounts of particulate microbiota (Apajalahti et al., 1998). The resulting matter and undigested food and a large diversity of bacterial cell pellets were immediately
Recommended publications
  • Standard Flow Multiplexed Proteomics (Sflompro) – an Accessible and Cost-Effective Alternative to Nanolc Workflows
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.25.964379; this version posted February 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Standard Flow Multiplexed Proteomics (SFloMPro) – An Accessible and Cost-Effective Alternative to NanoLC Workflows Conor Jenkins1 and Ben Orsburn2* 1Hood College Department of Biology, Frederick, MD 2University of Virginia Medical School, Charlottesville, VA *To whom correspondence should be addressed; [email protected] Abstract Multiplexed proteomics using isobaric tagging allows for simultaneously comparing the proteomes of multiple samples. In this technique, digested peptides from each sample are labeled with a chemical tag prior to pooling sample for LC-MS/MS with nanoflow chromatography (NanoLC). The isobaric nature of the tag prevents deconvolution of samples until fragmentation liberates the isotopically labeled reporter ions. To ensure efficient peptide labeling, large concentrations of labeling reagents are included in the reagent kits to allow scientists to use high ratios of chemical label per peptide. The increasing speed and sensitivity of mass spectrometers has reduced the peptide concentration required for analysis, leading to most of the label or labeled sample to be discarded. In conjunction, improvements in the speed of sample loading, reliable pump pressure, and stable gradient construction of analytical flow HPLCs has continued to improve the sample delivery process to the mass spectrometer. In this study we describe a method for performing multiplexed proteomics without the use of NanoLC by using offline fractionation of labeled peptides followed by rapid “standard flow” HPLC gradient LC-MS/MS.
    [Show full text]
  • W Yang Et Al. Proteomic Approaches to the Analysis of Multiprotein
    832 DOI 10.1002/pmic.200700650 Proteomics 2008, 8, 832–851 REVIEW Proteomic approaches to the analysis of multiprotein signaling complexes Wei Yang1, 2, Hanno Steen3 and Michael R. Freeman1, 2 1 The Urological Diseases Research Center, Department of Urology, Children’s Hospital Boston, Boston, MA, USA 2 Departments of Surgery, Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA 3 Department of Pathology, Harvard Medical School and Children’s Hospital Boston, Boston, MA, USA Signal transduction is one of the most active fields in modern biomedical research. Increasing Received: July 9, 2007 evidence has shown that signaling proteins associate with each other in characteristic ways to Revised: October 23, 2007 form large signaling complexes. These diverse structures operate to boost signaling efficiency, Accepted: October 23, 2007 ensure specificity and increase sensitivity of the biochemical circuitry. Traditional methods of protein analysis are inadequate to fully characterize and understand these structures, which are intricate, contain many components and are highly dynamic. Instead, proteomics technologies are currently being applied to investigate the nature and composition of multimeric signaling complexes. This review presents commonly used and potential proteomic methods of analyzing diverse protein complexes along with a discussion and a brief evaluation of alternative ap- proaches. Challenges associated with proteomic analysis of signaling complexes are also dis- cussed. Keywords: Cross-linking / Mass spectrometry / Post-translational modification / Quantitative proteomics / Signaling complexes 1 Introduction 1980s, astonishingly rapid progress has been made in understanding the mechanisms of signal transduction. The modern field of cell signaling can be traced back to the Many old concepts have been abandoned or revised and mid-1950s, when it was discovered that reversible phospho- new ones have emerged.
    [Show full text]
  • Metaproteomics As a Tool for Studying the Protein Landscape of Human-Gut Bacterial Species
    bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458484; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Metaproteomics as a tool for studying the protein landscape of human-gut bacterial species Moses Stamboulian1, Jamie Canderan1, and Yuzhen Ye1 1Luddy School of Informatics, Computing and Engineering, Indiana University, 700 N. Woodlawn Avenue, Bloomington, IN 47408. Email address: Moses Stamboulian, [email protected] Jamie Canderan, [email protected] Yuzhen Ye, [email protected] Corresponding author: Yuzhen Ye, [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458484; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Host-microbiome interactions and the microbial community have broad impact in human health and diseases. Most microbiome based studies are performed at the genome level based on next-generation sequencing techniques, but metaproteomics is emerging as a pow- erful technique to study microbiome functional activity by characterizing the complex and dynamic composition of microbial proteins. We conducted a large-scale survey of human gut microbiome metaproteomic data to identify generalist species that are ubiquitously expressed across all samples and specialists that are highly expressed in a small subset of samples associ- ated with a certain phenotype.
    [Show full text]
  • A Decade of Metaproteomics: Where We Stand and What the Future Holds
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Open Repository and Bibliography - Luxembourg www.proteomics-journal.com Page 1 Proteomics Viewpoint A decade of metaproteomics: where we stand and what the future holds Paul Wilmes1, Anna Heintz-Buschart1 and Philip L. Bond2 1Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg 2Advanced Water Management Centre, University of Queensland, Brisbane, Australia Correspondence: Paul Wilmes, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 avenue des Hauts-Fourneaux, L-4362 Esch-sur-Alzette, Luxembourg; Philip L. Bond, Advanced Water Management Centre, University of Queensland, Queensland 4072, Australia E-mail: [email protected]; [email protected] Fax: (352) 466644 6188; (61) 07 33654726 Received: 15-May-2015; Revised: 06-Jul-2015; Accepted: 05-Aug-2015. This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/pmic.201500183. This article is protected by copyright. All rights reserved. www.proteomics-journal.com Page 2 Proteomics Abstract We are living through exciting times during which we are able to unravel the “microbial dark matter” in and around us through the application of high-resolution “meta-omics”. Metaproteomics offers the ability to resolve the major catalytic units of microbial populations and thereby allows the establishment of genotype-phenotype linkages from in situ samples. A decade has passed since the term “metaproteomics” was first coined and corresponding analyses were carried out on mixed microbial communities.
    [Show full text]
  • And Metaproteomics-Based Rapid Assay of Individual 2 Microbiome Responses to Drugs
    bioRxiv preprint doi: https://doi.org/10.1101/543256; this version posted June 7, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 RapidAIM: A culture- and metaproteomics-based Rapid Assay of Individual 2 Microbiome responses to drugs 3 4 Authors: Leyuan Li1, Zhibin Ning1, Xu Zhang1, Janice Mayne1, Kai Cheng1, Alain Stintzi*1, 5 Daniel Figeys*1,2,3 6 Affiliations: 7 1 Department of Biochemistry, Microbiology and Immunology, Ottawa Institute of Systems Biology, Faculty of 8 Medicine, University of Ottawa, Ottawa, Canada. 9 2 Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Canada. 10 3 Canadian Institute for Advanced Research, Toronto, Canada. 11 *To whom correspondence should be addressed: Emails: [email protected] (DF), and [email protected] (AS). 12 13 Abstract: 14 Background: Human-targeted drugs may exert off-target effects on the gut microbiota. 15 However, our understanding of such effects is limited due to a lack of rapid and scalable assay to 16 comprehensively assess microbiome responses to drugs. Drugs can drastically change the overall 17 microbiome abundance, microbial composition and functions of a gut microbiome. Although we 18 could comprehensively observe these microbiome responses using a series of tests, for the 19 purpose of a drug screening, it is important to decrease the number of analytical tools used. 20 Results: Here, we developed an approach to screen compounds against individual microbiomes 21 in vitro using metaproteomics adapted for both absolute bacterial abundances and functional 22 profiling of the microbiome.
    [Show full text]
  • A Community Proposal to Integrate Proteomics Activities In
    F1000Research 2017, 6:875 Last updated: 05 OCT 2021 OPINION ARTICLE A community proposal to integrate proteomics activities in ELIXIR [version 1; peer review: 2 approved] Juan Antonio Vizcaíno 1, Mathias Walzer 1, Rafael C. Jiménez 2, Wout Bittremieux3, David Bouyssié4, Christine Carapito4, Fernando Corrales5, Myriam Ferro4, Albert J.R. Heck6,7, Peter Horvatovich 8, Martin Hubalek9, Lydie Lane10,11, Kris Laukens3, Fredrik Levander12, Frederique Lisacek13,14, Petr Novak15, Magnus Palmblad 16, Damiano Piovesan17, Alfred Pühler18, Veit Schwämmle 19, Dirk Valkenborg20-22, Merlijn van Rijswijk 23,24, Jiri Vondrasek9, Martin Eisenacher25, Lennart Martens26,27, Oliver Kohlbacher 28-31 1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, CB10 1SD, UK 2ELIXIR Hub, Cambridge, CB10 1SD, UK 3Department of Mathematics and Computer Science, University of Antwerp, Antwerp, 2020, Belgium 4French Proteomics Infrastructure ProFI, Grenoble, (EDyP U1038, CEA/Inserm/ Grenoble Alpes University) Toulouse (IPBS, Université de Toulouse, CNRS, UPS), Strasbourg (LSMBO, IPHC UMR7178, CNRS-Université de Strasbourg), France 5ProteoRed, Proteomics Unit, Centro Nacional de Biotecnología (CSIC), Madrid, 28049, Spain 6Biomolecular Mass Spectrometry and Proteomics, Bijvoet Centre for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, 3548 CH, The Netherlands 7Netherlands Proteomics Center, Utretcht, 3584 CH, The Netherlands 8Analytical Biochemistry, Department of Pharmacy,
    [Show full text]
  • Gut Microbiome’ on 7Th & 8Th June 2018 in Brussels
    THE ESSENTIAL ROLES OF CARBOHYDRATES IN PROMOTING GUT MICROBIOTA FUNCTION THROUGH ALL STAGES OF LIFE This paper was co-authored by Nathalie Juge†, Sabine Flitsch‡, Rodney Townsend§ and Claire Doherty‡ using input from group discussions that took place at the CarboMet workshop ‘The Role of Carbohydrates in the Gut Microbiome’ on 7th & 8th June 2018 in Brussels. CarboMet (Metrology of Carbohydrates for European Bioindustries) is a four-year Coordination and Support Action (CSA) funded by Horizon 2020 FET-OPEN (Grant agreement no. 737395). https://carbomet.eu/) The primary aim of the CSA is to mobilise the European academic and industrial community to identify generic measurement, data management and metrological challenges that must be met in order to advance and exploit carbohydrate knowledge and applications. The potential for exploitation of carbohydrates lies in their diversity and structural complexity – subtle changes in the three-dimensional structure of a carbohydrate profoundly affects (for example) its ability to protect against or fight infectious disease. However, these subtle structural differences present a challenge for their analysis. Sophisticated measurement and metrological capabilities for analysing carbohydrates are available but are nowhere near as advanced or as routinely used in other areas such as gene sequencing. Therefore as a first stage CarboMet has organised some open, Europe-wide workshops to identify key topics where our understanding needs to be advanced urgently, and where current limitations in our measurement, data management and metrological capabilities are hindering progress. The Workshops were also asked to recommend appropriate Work Programmes that should be supported by Horizon 2020 and its successor, Horizon Europe.
    [Show full text]
  • ANNUAL REPORT Marine Science Institute UC SANTA BARBARA Table of Contents
    2018–2019 ANNUAL REPORT Marine Science Institute UC SANTA BARBARA Table of Contents 3 Mission Statement 4 From the Director Overview 5 Executive Summary 7 10 Organizational Charts Administrative Staff 11 Centers and Units 12 13 MSI Advisory Committee, Administrative & Technical Staff 16 Statistical Summary Research Support Summary 17 Statistical Summary 2018–2019 19 Five-Year Research Support 21 Summary Funding Agencies 22 24 Principal Investigators 30 Postdoctoral Researchers, Graduate and Undergraduate Students 33 Space 39 Other Projects & Activities Coastal Research Center 40 Marine Biotechnology Center 42 Ocean & Coastal Policy Center 52 Analytical Laboratory 54 Education and Outreach 55 56 Awards Administered Awards 57 Research Summaries 66 2 Mission Statement The Marine Science Institute at the University of California, Santa Barbara, is committed to fostering innovative and significant research, to promoting effective stewardship, and to sharing exciting discoveries of the world’s oceans. 3 From the Director 4 Overview The Marine Science Institute (MSI) provides an intellectual and physical environment at UCSB that fosters world-renowned marine research. The institute brings together marine researchers from across the UCSB campus and supports multi-investigator collaborative projects and individual research efforts. The scientific membership at MSI consists of both ladder faculty and professional researchers. In 2018-2019 MSI membership included 25 ladder faculty and 32 professional researchers with 228 additional participants distributed across postdoctoral scholars, graduate students and undergraduates. Beyond research, MSI’s Research Experience and Education Facility (REEF) educates UCSB students and the general public about MSI science. MSI is housed in the marine science research building (MSRB) on the UCSB campus.
    [Show full text]
  • Proteomics in Forensic Analysis: Applications for Human Samples
    applied sciences Review Proteomics in Forensic Analysis: Applications for Human Samples Van-An Duong 1,† , Jong-Moon Park 1,† , Hee-Joung Lim 2,* and Hookeun Lee 1,* 1 College of Pharmacy, Gachon University, Incheon 21936, Korea; [email protected] (V.-A.D.); [email protected] (J.-M.P.) 2 Forensic Science Center for Odor Fingerprint Analysis, Police Science Institute, Korean National Police University, Asan 31539, Korea * Correspondence: [email protected] (H.-J.L.); [email protected] (H.L.); Tel.: +82-41-968-2893 (H.-J.L.); +82-32-820-4927 (H.L.) † These authors contributed equally. Abstract: Proteomics, the large-scale study of all proteins of an organism or system, is a powerful tool for studying biological systems. It can provide a holistic view of the physiological and biochemical states of given samples through identification and quantification of large numbers of peptides and proteins. In forensic science, proteomics can be used as a confirmatory and orthogonal technique for well-built genomic analyses. Proteomics is highly valuable in cases where nucleic acids are absent or degraded, such as hair and bone samples. It can be used to identify body fluids, ethnic group, gender, individual, and estimate post-mortem interval using bone, muscle, and decomposition fluid samples. Compared to genomic analysis, proteomics can provide a better global picture of a sample. It has been used in forensic science for a wide range of sample types and applications. In this review, we briefly introduce proteomic methods, including sample preparation techniques, data acquisition using liquid chromatography-tandem mass spectrometry, and data analysis using database search, Citation: Duong, V.-A.; Park, J.-M.; spectral library search, and de novo sequencing.
    [Show full text]
  • Challenges in Clinical Metaproteomics Highlighted by the Analysis of Acute Leukemia Patients with Gut Colonization by Multidrug-Resistant Enterobacteriaceae
    proteomes Article Challenges in Clinical Metaproteomics Highlighted by the Analysis of Acute Leukemia Patients with Gut Colonization by Multidrug-Resistant Enterobacteriaceae Julia Rechenberger 1,† , Patroklos Samaras 1,†, Anna Jarzab 1, Juergen Behr 2, Martin Frejno 1 , Ana Djukovic 3, Jaime Sanz 4,5, Eva M. González-Barberá 4, Miguel Salavert 4, Jose Luis López-Hontangas 4, Karina B. Xavier 6 , Laurent Debrauwer 7,8, Jean-Marc Rolain 9, Miguel Sanz 4,5 , Marc Garcia-Garcera 10, Mathias Wilhelm 1,* , Carles Ubeda 3,11,* and Bernhard Kuster 1,2,* 1 Chair of Proteomics and Bioanalytics, Technical University of Munich, 85354 Freising, Germany; [email protected] (J.R.); [email protected] (P.S.); [email protected] (A.J.); [email protected] (M.F.) 2 Bavarian Center for Biomolecular Mass Spectrometry, Technical University of Munich, 85354 Freising, Germany; [email protected] 3 Centro Superior de Investigación en Salud Pública-FISABIO, 46020 Valencia, Spain; [email protected] 4 Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain; [email protected] (J.S.); [email protected] (E.M.G.-B.); [email protected] (M.S.); [email protected] (J.L.L.-H.); [email protected] (M.S.) 5 CIBERONC, Instituto Carlos III, 28029 Madrid, Spain 6 Instituto Gulbenkian de Ciência, 2780 Oeiras, Portugal; [email protected] 7 Toxalim, Université de Toulouse, INRA, INP-ENVT, INP-EI-Purpan, Université de Toulouse 3 Paul Sabatier, 31027 Toulouse, France; [email protected] 8 Axiom Platform, UMR 1331 Toxalim, MetaToul-MetaboHUB,
    [Show full text]
  • Metaproteomics Characterizes Human Gut Microbiome Function In
    www.nature.com/npjbiofilms ARTICLE OPEN Metaproteomics characterizes human gut microbiome function in colorectal cancer ✉ ✉ Shuping Long1,2,3,5, Yi Yang 1,5, Chengpin Shen4, Yiwen Wang 1, Anmei Deng2, Qin Qin2 and Liang Qiao 1 Pathogenesis of colorectal cancer (CRC) is associated with alterations in gut microbiome. Previous studies have focused on the changes of taxonomic abundances by metagenomics. Variations of the function of intestinal bacteria in CRC patients compared to healthy crowds remain largely unknown. Here we collected fecal samples from CRC patients and healthy volunteers and characterized their microbiome using quantitative metaproteomic method. We have identified and quantified 91,902 peptides, 30,062 gut microbial protein groups, and 195 genera of microbes. Among the proteins, 341 were found significantly different in abundance between the CRC patients and the healthy volunteers. Microbial proteins related to iron intake/transport; oxidative stress; and DNA replication, recombination, and repair were significantly alternated in abundance as a result of high local concentration of iron and high oxidative stress in the large intestine of CRC patients. Our study shows that metaproteomics can provide functional information on intestinal microflora that is of great value for pathogenesis research, and can help guide clinical diagnosis in the future. npj Biofilms and Microbiomes (2020) 6:14 ; https://doi.org/10.1038/s41522-020-0123-4 1234567890():,; INTRODUCTION abundances of samples. Nevertheless, biases can exist due to DNA Colorectal cancer (CRC) is the third most commonly diagnosed extraction methods, the use of amplification primers, and cancer and the fourth leading cause of oncological mortality bioinformatic tools12,13.
    [Show full text]
  • Metaproteomic Analysis of Human Gut Microbiota: Where Are We Heading? Pey Yee Lee, Siok-Fong Chin*, Hui-Min Neoh and Rahman Jamal
    Lee et al. Journal of Biomedical Science (2017) 24:36 DOI 10.1186/s12929-017-0342-z REVIEW Open Access Metaproteomic analysis of human gut microbiota: where are we heading? Pey Yee Lee, Siok-Fong Chin*, Hui-min Neoh and Rahman Jamal Abstract The human gut is home to complex microbial populations that change dynamically in response to various internal and external stimuli. The gut microbiota provides numerous functional benefits that are crucial for human health but in the setting of a disturbed equilibrium, the microbial community can cause deleterious outcomes such as diseases and cancers. Characterization of the functional activities of human gut microbiota is fundamental to understand their roles in human health and disease. Metaproteomics, which refers to the study of the entire protein collection of the microbial community in a given sample is an emerging area of research that provides informative details concerning functional aspects of the microbiota. In this mini review, we present a summary of the progress of metaproteomic analysis for studying the functional role of gut microbiota. This is followed by an overview of the experimental approaches focusing on fecal specimen for metaproteomics and is concluded by a discussion on the challenges and future directions of metaproteomic research. Keywords: Metaproteomics, Human, Gut Microbiota, Multi-omics, Technologies Background that aims to provide a reference catalog of gut microbiome The human gastrointestinal (GI) tract is colonized by a in association with obesity and inflammatory bowel highly diverse population of microbial community collect- disease (IBD) [6]. Over the years, much effort has been ively known as the gut microbiota that play vital roles in devoted to determine microbiome composition in various maintaining human health [1].
    [Show full text]